AI-Driven Peptide Drug Discovery
Date and Time
Wednesday Jun 11, 2025
6:00 PM - 9:00 PM EDT
Location
Sam IT Solutions
2511 E NC-54
Durham, NC 27713
Fees/Admission
Fee: $20 (To be paid at the venue)
Registration Link for this event
https://forms.gle/
Contact Information
Samudra Vijay
Send Email
Description
Speaker: Ved Srivastava, Ph.D., Chief Technology Officer, Perpetual Medicines, Boston, MA.
Topic: AI-Driven Peptide Drug Discovery: Revolutionizing Tomorrow’s Therapeutics
Peptide therapeutics represent a groundbreaking approach in the biopharmaceutical industry,
providing innovative solutions for various medical conditions, including success in treating
metabolic diseases such as GLP-1 class drugs such as Wegovy and Mounjaro for diabetes and
Obesity. The global peptide therapeutics market is projected to reach $117.4 billion by 2034,
with a compound annual growth rate (CAGR) of 10.8% during the forecast period
(pharmiweb.com/press-release/
computational AI/ML and the robust prediction of protein structures are showing promising
progress in developing clinical candidates. However, we are still in the early stages.
This presentation will cover technological advancements and a case study in transitioning from
traditional drug discovery methods to Computational/AI-driven platforms for developing
peptide-based therapies in the AI era.
providing innovative solutions for various medical conditions, including success in treating
metabolic diseases such as GLP-1 class drugs such as Wegovy and Mounjaro for diabetes and
Obesity. The global peptide therapeutics market is projected to reach $117.4 billion by 2034,
with a compound annual growth rate (CAGR) of 10.8% during the forecast period
(pharmiweb.com/press-release/
computational AI/ML and the robust prediction of protein structures are showing promising
progress in developing clinical candidates. However, we are still in the early stages.
This presentation will cover technological advancements and a case study in transitioning from
traditional drug discovery methods to Computational/AI-driven platforms for developing
peptide-based therapies in the AI era.
